|
|
|
|
| LEADER |
01000naa a22002652 4500 |
| 001 |
NLM181715414 |
| 003 |
DE-627 |
| 005 |
20231223161728.0 |
| 007 |
tu |
| 008 |
231223s2008 xx ||||| 00| ||eng c |
| 028 |
5 |
2 |
|a pubmed24n0606.xml
|
| 035 |
|
|
|a (DE-627)NLM181715414
|
| 035 |
|
|
|a (NLM)18717028
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Marino, Mark T
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a DPP-4 inhibitors. A new class of drugs for type 2 diabetes
|
| 264 |
|
1 |
|c 2008
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 26.08.2008
|
| 500 |
|
|
|a Date Revised 19.11.2015
|
| 500 |
|
|
|a published: Print
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
7 |
|a Dipeptidyl-Peptidase IV Inhibitors
|2 NLM
|
| 650 |
|
7 |
|a Hypoglycemic Agents
|2 NLM
|
| 650 |
|
7 |
|a Protease Inhibitors
|2 NLM
|
| 650 |
|
7 |
|a Pyrazines
|2 NLM
|
| 650 |
|
7 |
|a Triazoles
|2 NLM
|
| 650 |
|
7 |
|a DPP4 protein, human
|2 NLM
|
| 650 |
|
7 |
|a EC 3.4.14.5
|2 NLM
|
| 650 |
|
7 |
|a Dipeptidyl Peptidase 4
|2 NLM
|
| 650 |
|
7 |
|a EC 3.4.14.5
|2 NLM
|
| 650 |
|
7 |
|a Sitagliptin Phosphate
|2 NLM
|
| 650 |
|
7 |
|a TS63EW8X6F
|2 NLM
|
| 773 |
0 |
8 |
|i Enthalten in
|t Diabetes self-management
|d 1998
|g 25(2008), 4 vom: 26. Juli, Seite 60, 62-4
|w (DE-627)NLM098190385
|x 0741-6253
|7 nnns
|
| 773 |
1 |
8 |
|g volume:25
|g year:2008
|g number:4
|g day:26
|g month:07
|g pages:60, 62-4
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 25
|j 2008
|e 4
|b 26
|c 07
|h 60, 62-4
|